Hypothesis: hypothalamic dysfunction and lipoatrophic diabetes

Yale J Biol Med. 1973 Oct;46(4):314-23.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenylyl Cyclases / metabolism
  • Adrenocorticotropic Hormone / pharmacology
  • Animals
  • Biogenic Amines
  • Catecholamines / antagonists & inhibitors
  • Corticotropin-Releasing Hormone / blood
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / metabolism
  • Diabetes Mellitus / physiopathology*
  • Dopamine / biosynthesis
  • Dopamine / pharmacology
  • Dopamine beta-Hydroxylase / blood
  • Dopamine beta-Hydroxylase / metabolism
  • Feedback
  • Follicle Stimulating Hormone / blood
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Hypothalamo-Hypophyseal System / drug effects
  • Hypothalamo-Hypophyseal System / physiopathology
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • Hypothalamus / physiopathology*
  • Luteinizing Hormone / blood
  • Melanins / metabolism
  • Melanocyte-Stimulating Hormones / blood
  • Neurosecretory Systems / drug effects
  • Norepinephrine / biosynthesis
  • Norepinephrine / pharmacology
  • Pigmentation
  • Pituitary Hormones, Anterior / metabolism
  • Tyrosine / metabolism
  • Tyrosine / pharmacology

Substances

  • Biogenic Amines
  • Catecholamines
  • Hypoglycemic Agents
  • Melanins
  • Pituitary Hormones, Anterior
  • Tyrosine
  • Adrenocorticotropic Hormone
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Melanocyte-Stimulating Hormones
  • Corticotropin-Releasing Hormone
  • Dopamine beta-Hydroxylase
  • Adenylyl Cyclases
  • Dopamine
  • Norepinephrine